Overview

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
Treatments:
Cetirizine
Fexofenadine
Levocetirizine